Outside of the use of mobile devices by pharma sales reps, pharma’s movements in digital health over the past few years have fallen broadly under a few basic umbrellas: patient engagement tools, including medication adherence, prescribable digital therapies, new kinds of sensors, and big data initiatives. Like payers, though, pharma companies aren’t limiting themselves to areas that relate directly to their core business of selling drugs and therapies.

Digital Health will transform the business models of the Pharmaceutical industry. Although many companies have not yet formulated a concise Digital Health strategy, industry executives expect that by 2020, Digital Health will enable Pharmaceutical companies to activate new business segments as well as to significantly improve their competitive advantage.

Successful implementation of Digital Health strategies will result in transformation across four areas:

  • Organizational prioritization: Digital Health will need to transform into a leadership topic.
  • Shift in customer base: the role of patients, consumers and payers are about to change.
  • New competencies and partnerships: there will be a need to master a changed set of competencies and engage with different partners.
  • Uncertain revenue streams: when Digital Health elements become an integrated part of product offerings, new financial models will be needed
pharma-bio

Medication adherence is one focus area where the rewards for pharmaceutical companies are very much self-evident: getting patients to actually take the drugs prescribed to them improves health outcomes, could save the healthcare system an estimated $290 billion per year, and, to the pharma company’s benefit, helps sell more drugs.

Recently, Medidata Teams Up with Garmin to Optimize Clinical Trials through Mobile Health TechnologyThe other most obvious area of focus for mobile health in pharma is the clinical trial. Mobile startups are focused on innovating nearly every aspect of the clinical trial including recruitment, informed consent forms, data reporting, and training of investigators.

HealthCursor actively works with  CRO services where demand is driven by small and medium sized pharma companies, as 60-80% of the intellectual property (IP) resides within these companies.  Thus, CROs need to build solutions that are low in cost with the minimal infrastructure footprint and generating quick ROI.

Larger pharma companies are focusing on long-term strategic alliances or one-stop-shops boasting broad service offerings that include non-traditional capabilities such as health economics and outcomes research (HEOR), market access, and pharmacovigilance.

Improving health outcomes could save an estimated $290 billion per year

  • HealthCursor has the expertise in key functional areas, as listed below, which can add value to CRO offerings.
  • Unique solutions for market access and patient recruitment and retention
  • Our Partner’s framework, which can integrate the three stages of information, intelligence and interaction to motivate patients to adhere to therapy
  • Implementation, ASM, system validation, case processing, and aggregate reporting services
  • eClinical and transformational  consulting, and unique  transformation solutions aimed at enabling CROs offer cost competitive and improved services to their sponsors

Strategy Insights

Technology solving problems relating to Drug Counterfeiting and Supply chain management

The Technology Driven data channels offers a key opportunity for pharma companies to restructure their sales and marketing model, improving their relationships with physicians and increasing compliance among patients. At the same time, patients are demanding a greater role in treatment decisions and seeking information from a range of online sources, resulting in a new age of consumerism in healthcare. Read More>>

Pharma Companies looking for affordable solutions

Managing prescription order workflow in a pharmacy network can be done using mobile phones. A workflow may define a sequence of queues. In the SWOT analysis of Big Pharma majors, Counterfeit was reflected as a common problem.Bad medicines don’t just threaten lives; they undermine the entire medical system.Read more>>

Case Studies

Specialised Apps launched by major pharmas is to engage Doctors as well as patients-Novartis Oncology, a division of the Switzerland-based pharmaceutical company, has added two new free Apple and Android apps to its catalog: My NET Manage and Clinical Trial Seek. Interestingly, one of their most high-profile apps, VaxTrak, has now disappeared from the Apple and Google Play stores.

My NET Manager is an app for patients with neuroendocrine tumors (or NET) to help them manage and learn about their condition. It provides tools for users to track their symptoms, set reminders for treatments, doctor visits, and medication refills, and review and track test results. The app also stores contact information for a patients’ healthcare team and enables the patient to share information with their team. Finally, the app can help NET patients track insurance claims.Read More>>

e-Pharmacy service and lessons learnt – Currently, Pharma products are sold through bricks-and-mortar retail pharmacies and a smaller percentage, particularly prescription pharmaceuticals for chronic conditions, are purchased by mail.The company’s long-term goal involves development of a comprehensive pharmacy services vertical portal-delivering all aspects of pharmacy services to consumers as well as business constituencies within the healthcare industry. The online pharmacy allows customers, via the Internet, to receive comprehensive drug and healthcare information, and correspond privately with pharmacists. Read More>>